Holbrook, A.M. et al. 2018. PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN. Journal of Population Therapeutics and Clinical Pharmacology. 20, 3 (Nov. 2018).